Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) – Research analysts at Leerink Partnrs boosted their Q3 2025 earnings per share estimates for shares of Privia Health Group in a report issued on Tuesday, September 23rd. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings per share of $0.09 for the quarter, up from their previous forecast of $0.08. The consensus estimate for Privia Health Group’s current full-year earnings is $0.14 per share.
Get Privia Health Group alerts:
Privia Health Group (NASDAQ:PRVA – Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.03). Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.The firm had revenue of $521.15 million during the quarter, compared to analysts’ expectations of $466.97 million. During the same period last year, the business posted $0.19 EPS. The company’s revenue was up 23.4% compared to the same quarter last year. Privia Health Group has set its FY 2025 guidance at EPS.
PRVA has been the subject of a number of other research reports. Evercore ISI dropped their target price on Privia Health Group from $30.00 to $28.00 and set an “outperform” rating for the company in a research report on Wednesday, July 9th. JPMorgan Chase & Co. upped their price target on Privia Health Group from $29.00 to $32.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 28th. Zacks Research raised Privia Health Group from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 19th. Citigroup reaffirmed an “outperform” rating on shares of Privia Health Group in a research note on Friday, August 29th. Finally, Piper Sandler reduced their price target on Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a research note on Monday, August 11th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $28.58.
Get Our Latest Research Report on PRVA
Privia Health Group Trading Down 0.6%
Shares of PRVA opened at $23.34 on Wednesday. The company has a market cap of $2.86 billion, a PE ratio of 212.20, a price-to-earnings-growth ratio of 3.40 and a beta of 0.82. The stock has a 50-day moving average price of $21.39 and a 200-day moving average price of $22.40. Privia Health Group has a 12-month low of $16.47 and a 12-month high of $26.09.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of PRVA. Bessemer Group Inc. increased its position in Privia Health Group by 2,393.4% during the first quarter. Bessemer Group Inc. now owns 2,269 shares of the company’s stock valued at $51,000 after acquiring an additional 2,178 shares during the last quarter. Janney Montgomery Scott LLC increased its position in Privia Health Group by 4.6% in the first quarter. Janney Montgomery Scott LLC now owns 55,371 shares of the company’s stock worth $1,243,000 after buying an additional 2,413 shares in the last quarter. GAMMA Investing LLC increased its position in Privia Health Group by 113.1% in the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock worth $64,000 after buying an additional 1,521 shares in the last quarter. Strs Ohio purchased a new stake in Privia Health Group in the first quarter worth about $849,000. Finally, Teacher Retirement System of Texas purchased a new stake in Privia Health Group in the first quarter worth about $387,000. 94.48% of the stock is owned by institutional investors.
Privia Health Group Company Profile
(Get Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Featured Stories
Five stocks we like better than Privia Health Group
How to Use the MarketBeat Excel Dividend Calculator
Cybersecurity Market Set to Double: This ETF Offers Exposure
Stock Market Upgrades: What Are They?
Downgraded But Not Done: 3 Stocks Ready for a Market Comeback
Mastering Discipline: Overcoming Emotional Challenges In Trading
Solana Beat BTC and ETH in Q3: These 3 Stocks Saw It Coming